ArticleBiochemistry and biophysics reports2026
Antimicrobial efficacy of carbon nanotube-based nano drug on
Article in Biochemistry and biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The most common form of nosocomial infection is urinary tract infection, which is more prevalent among women. Methods: In this study, thionyl chloride has been used as an agent for the activation of multi-walled carbon nanotubes (MWCNTs) through a reflux system. Moreover, nanofluids containing antibiotics were prepared through an ultrasonic approach. Different methodologies, including general element analysis, infrared spectroscopy, Raman spectroscopy, scanning electron microscopy, and transmission electron microscopy, have been applied to study the properties of the nano-drugs that were prepared. Following the treatment of the desired strain with the nanofluid, microbial studies were performed to evaluate the respective antibacterial effects. Finally, the Result: The results showed that the antimicrobial effect of functionalized MWCNTs with AMP (AMP-MWCNT) at low concentrations is higher than that of conventional drugs in both resistant and standard strains. Compared to the pure drug, a significant reduction in bacterial antibiotic resistance under AMP-MWCNT treatment has been observed. It was also found that the Conclusion: Our study shows that the antimicrobial effect of low-concentration AMP-MWCNT is greater than that of the conventional drug used in resistant strains. A decrease in antibiotic resistance of bacteria treated with AMP-MWCNT was also observed compared to the free drug. Moreover, the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.